ESPERION THERAPEUTICS INC (ESPR) Stock News
NASDAQ:ESPR - US29664W1053 - Common Stock
2.53 USD
+0.1 (+4.12%)
2.5384 USD
+0.01 (+0.33%)
ESPR Latest News, Press Relases and Analysis
All
Press Releases
7 days ago - By: Esperion Therapeutics, Inc.
7 days ago - By: Esperion Therapeutics, Inc.
10 days ago - By: Esperion Therapeutics, Inc.
13 days ago - By: Zacks Investment Research
a month ago - By: The Motley Fool
a month ago - By: Benzinga
2 months ago - By: Esperion Therapeutics, Inc.
a month ago - By: Esperion Therapeutics, Inc.
a month ago - By: Esperion Therapeutics, Inc.
a month ago - By: Zacks Investment Research - Mentions: NOTV
a month ago - By: Esperion Therapeutics, Inc.
a month ago - By: Esperion Therapeutics, Inc.
a month ago - By: Zacks Investment Research - Mentions: BCRX
a month ago - By: Yahoo Finance
a month ago - By: Esperion Therapeutics, Inc.
a month ago - By: Esperion Therapeutics, Inc.
2 months ago - By: Esperion Therapeutics, Inc.
2 months ago - By: Esperion Therapeutics, Inc.
2 months ago - By: Esperion Therapeutics, Inc.
3 months ago - By: Zacks Investment Research - Mentions: IONS
3 months ago - By: Esperion Therapeutics, Inc.
4 months ago - By: Esperion Therapeutics, Inc.
4 months ago - By: Esperion Therapeutics, Inc.
4 months ago - By: Esperion Therapeutics, Inc.
4 months ago - By: Esperion Therapeutics, Inc.
4 months ago - By: Esperion Therapeutics, Inc.
4 months ago - By: Esperion Therapeutics, Inc.
4 months ago - By: Esperion Therapeutics, Inc.
4 months ago - By: Esperion Therapeutics, Inc.
4 months ago - By: Esperion Therapeutics, Inc.
4 months ago - By: Zacks Investment Research - Mentions: MGX
4 months ago - By: Esperion Therapeutics, Inc.